Skip to main content

Table 1 Schedule of visits and measures in the control arm

From: Rationale and design of the Adapted Physical Activity in advanced Pancreatic Cancer patients (APACaP) GERCOR (Groupe Coopérateur Multidisciplinaire en Oncologie) trial: study protocol for a randomized controlled trial

 

Screening visit

Randomization visit

Study visit

End of treatment

Follow-up visit

D7

D0

W2

W4

W6

W8

W10

W12

W14

W16

W20

M6

M8

M10

M12

M14

M16

M18

M20

M22

M24

Informed consent

X

                    

Randomization

 

X

                   

Inclusion criteria

X

                   

Physical activity partner

X

                   

Physical activity level GPAQ

X

                   

Demographic and clinical data

X

                    

Concomitant treatment

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Pathological data

X

                   

Clinician visit

X

X

   

X

   

X

 

X

X

X

X

X

X

X

X

X

X

Physical exam

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

ECG

X

                    

Questionnaires

 

X

   

X

   

X

X

X

X

X

X

X

X

X

X

X

X

6-minute walking test

 

X

   

X

   

X

 

X

  

X

  

X

  

X

Maximal strength test

 

X

   

X

   

X

 

X

  

X

  

X

  

X

Body composition

 

X

   

X

   

X

 

X

  

X

  

X

  

X

Physical activity level IPAQ

 

X

   

X

   

X

 

X

  

X

  

X

  

X

Biology tests

                     

Type 1

 

X

   

X

   

X

 

X

  

X

  

X

  

X

Type 2

X

 

X

 

X

 

X

 

X

 

X

 

X

X

 

X

X

 

X

X

 

Type 3

   

X

   

X

             

Biobank (optional)

 

X

                   

TAP-CT

X

   

Xa

   

X

 

X

X

X

X

X

X

X

X

X

X

CA-19.9

X

   

Xa

   

X

 

X

X

X

X

X

X

X

X

X

X

Adverse events

  

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

  1. CA 19–9 carbohydrate antigen 19–9, CRP C-reactive protein, GPAQ Global Physical Activity Questionnaire, HbA1c glycated hemoglobin, HOMA homeostasis model assessment, IGF-1 insulin-like growth factor 1, IPAQ International Physical Activity Questionnaire, TAP-CT thoraco-abdominopelvic computed tomography
  2. aA +/− 2-week time interval is considered as acceptable
  3. Biology tests - type 1: blood cell count, CRP, fasting glucose, HbA1c, insulin/HOMA, IGF-1, albumin, prealbumin
  4. Biology tests - type 2: blood cell count, CRP, fasting glucose, albumin, prealbumin
  5. Biology tests - type 3: blood cell count, CRP, fasting glucose, insulin/HOMA, IGF-1, albumin, prealbumin
  6. X: to be performed at this timepoint